Komori
Mochida Pharmaceutical (4534) · InitiativeRestated

Enhancing the objectivity of appointment, removal and remuneration decisions through the Personnel and Remuneration Committee

First written in FY2019. 7 of 8 entries say "Restated". Latest entry: FY2026.

8entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20262019: 220192020: 220202021: 120212022: 120222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies
Operation of the Nomination and Compensation Committee Centered on Independent Outside DirectorsA theme 192 companies write about · 0 as a headwind · 192 as a tailwind

The whole theme swung hardest in 2025: 9 of 89 companies on the "Worse" side.

87 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「In addition, for the appointment and dismissal of senior management, the nomination of candidates for director and the proposed remuneration of senior management and directors, the Company has established, to strengthen objectivity and accountability, a personnel and remuneration committee as an optional advisory body to the representative directors, with independent outside directors constituting a majority of its members, and makes corporate decisions based on the committee’s opinions.」

    The company continues to strengthen the objectivity of decisions on appointment and dismissal, nominations and remuneration through a personnel and remuneration committee in which independent outside directors constitute a majority.
  2. FY2025RestatedAnnual report

    「For the appointment and dismissal of senior management, the nomination of candidates for director and the proposed remuneration of senior management and directors, the Company has established, to strengthen objectivity and accountability, a personnel and remuneration committee as an optional advisory body to the representative directors, with independent outside directors constituting a majority of its members, and makes corporate decisions based on the committee’s opinions.」

    The company continues to strengthen the objectivity of decisions on appointment and dismissal, nominations, and remuneration through a personnel and remuneration committee in which independent outside directors constitute a majority.
  3. FY2022RestatedAnnual report

    「The Company has established a personnel and remuneration committee in which independent outside directors constitute a majority, and makes corporate decisions based on the committee’s opinions.」

    The company continues its initiative to strengthen the objectivity and accountability of decisions on appointment and dismissal, nominations, and remuneration through a personnel and remuneration committee in which independent outside directors constitute a majority.
  4. FY2021RestatedAnnual report

    「For the appointment and dismissal of senior management, the nomination of candidates for director and the proposed remuneration of senior management and directors, the Company has established, to strengthen objectivity and accountability, a personnel and remuneration committee as an optional advisory body to the representative directors, with independent outside directors constituting a majority of its members, and makes corporate decisions based on the committee’s opinions.」

    The company reaffirms its initiative to strengthen the objectivity and accountability of decisions on appointment and dismissal, nominations, and remuneration through a personnel and remuneration committee in which outside directors constitute a majority.
  5. FY2020RestatedAnnual report

    「In addition, to enhance objectivity and accountability concerning the appointment and dismissal of senior management, the nomination of director candidates, and proposals for the remuneration of senior management and directors, the company has established a personnel and remuneration committee as an optional advisory body to the representative directors, with outside directors comprising a majority of its members, and makes institutional decisions based on the committee's opinions.」

    The company reaffirms its initiative to strengthen the objectivity and accountability of decisions on appointment and dismissal, nominations, and remuneration through a personnel and remuneration committee in which outside directors constitute a majority.
  6. FY2020-Q3RestatedAnnual report

    「In addition, to enhance objectivity and accountability concerning the appointment and dismissal of senior management, the nomination of director candidates, and proposals for the remuneration of senior management and directors, the company has established a personnel and remuneration committee as an optional advisory body to the representative directors, with outside directors comprising a majority of its members, and makes institutional decisions based on the committee's opinions.」

    The company reaffirms its initiative to strengthen the objectivity and accountability of decisions on appointment and dismissal, nominations, and remuneration through a personnel and remuneration committee in which outside directors constitute a majority.
  7. FY2020-Q2RestatedAnnual report

    「In addition, to enhance objectivity and accountability concerning the appointment and dismissal of senior management, the nomination of director candidates, and proposals for the remuneration of senior management and directors, the company has established a personnel and remuneration committee as an optional advisory body to the representative directors, with outside directors comprising a majority of its members, and makes institutional decisions based on the committee's opinions.」

    The company reaffirms its initiative to strengthen the objectivity and accountability of decisions on appointment and dismissal, nominations, and remuneration through a personnel and remuneration committee in which outside directors constitute a majority.
  8. FY2019First statedAnnual report

    「To strengthen objectivity and accountability regarding the appointment and dismissal of executive officers, the nomination of officer candidates, and compensation proposals for executive officers and directors, the Company has established a Nomination and Compensation Committee as a voluntary advisory body to the Representative Director. Outside directors constitute a majority of the committee, and corporate decisions are made based on the committee’s opinions.」

    The establishment of a personnel and remuneration committee as an optional advisory body to the representative directors is disclosed for the first time as a standalone initiative.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Mochida Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Enhancing the objectivity of appointment, removal and remuneration decisions through the Personnel and Remuneration Committee | Mochida Pharmaceutical Co.,Ltd. (4534) | Komori